9:10am ET
Investing
Massive Energy Trade Highlights High-Profile Insider Selling This Week
While the volume for insider trading has dropped dramatically due to earnings reporting, some very large trades hit the tape this week.
AMGN Coverage Page 30
10:30am ET
Investing
3 Top Stocks to Buy That Delivered Great Earnings
A new research report from Cowen features three top stocks of companies that exceeded earnings estimates that the firm feels should be bought now.
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Barrick, Facebook, Halcon, Qualcomm, Synchrony, Texas Instruments and More
Thursday's top analyst upgrades, downgrades and initiations include Barrick Gold, Facebook, Halcon Resources, Qualcomm, Synchrony Financial and Texas Instruments.
4:29pm ET
Health and Healthcare
Amgen Earnings Point to More Froth in the Biotech Sector
Amgen reported better-than-expected first-quarter 2015 earnings Tuesday afternoon after equity markets had closed.
Paul Ausick 11:35am ET
Health and Healthcare
Will Amgen Earnings Shape Biotech for the Rest of 2015?
After markets close on Tuesday, Amgen, the second-largest biotech, is scheduled to announce its first-quarter results.
8:35am ET
Health and Healthcare
Short Sellers Increase Their Bets Against Biotech Stocks
The March 31 short interest data have been compared with the March 13 figures, and for most of the selected biotech stocks, short interest has increased.
3:27pm ET
Investing
Goldman Sachs Cheapest Stocks, 6 Best Sector By Sector
Jon OggIf there is one firm on Wall Street that investors have been told that they want to pay attention to during analyst upgrades and downgrades, it is Goldman Sachs. The firm has…
12:45pm ET
Health and Healthcare
Is a Big Share Buyback Coming to DaVita?
DaVita Healthcare Partners has a large amount of cash on its balance sheet and it does not pay a dividend. Should investors should expect a big stock buyback?
8:15am ET
Health and Healthcare
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
One thing that can always drive a biotech stock higher is positive clinical data, and this week some big-time biotech companies could have some very import clinical data releases.
9:15am ET
Health and Healthcare
Short Sellers Get More Aggressive on Big Biotech
24/7 Wall St. has reviewed the top biotech companies, and the February 27 short interest data have been compared with the mid-February figures. Across the board, all the selected stocks have seen…
9:25am ET
Health and Healthcare
Short Sellers Increase Bets Against Biotech as Shares Continue to Rise
The short interest data are out for the February 13 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
8:25am ET
Health and Healthcare
Analyst’s 4 Blue-Chip Biotech Stocks to Buy for the Rest of 2015
Here are the four top biotech stocks to buy now according to Deutsche Bank. These leaders have established drugs, solid pipelines and, most importantly, earnings.
9:40am ET
Health and Healthcare
Short Sellers Look Scared of Big Biotech
The short interest data are out for the January 30 settlement date. 24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies.
9:10am ET
Investing
Insiders Aggressively Buy Shares as Market Rockets Higher
Logically, it seems that as they stock market zooms higher, insiders who want to buy stock would wait until a pullback to add new capital.
10:45am ET
Health and Healthcare
Gilead Dividend and Buyback Different From Amgen’s Strategy
Gilead Sciences has become so large and accumulated enough capital that it has decided to begin paying a dividend, a move follows Amgen.